EUVIMEDObjevte EUVIMED
BeobachtungsstudieKohortenstudieOpen access · CC BY 4.0

Predictors for regression and progression of actively surveilled cervical intraepithelial neoplasia grade 2: A prospective cohort study

Laura Bergqvist iD, Anni Virtanen iD, Ilkka Kalliala, Ralf Bützow, Maija Jakobsson, Annu Heinonen, Karolina Louvanto iD, Joakim Dillner, Pekka Nieminen, Karoliina Aro iD

Acta Obstetricia et Gynecologica Scandinavica · 2025-04 · 104 (4) · 763-773

DOI: 10.1111/aogs.15032 ↗

At a glance

Beobachtungsstudie in Acta Obstetricia et Gynecologica Scandinavica, published online on 2025-02-10. Written by Laura Bergqvist and 9 co-authors. Institution: Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland. Major MEDLINE topics: Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Papillomavirus Infections. Cited 15 times so far (Crossref); 32 references. The full text is freely available (open access, CC BY 4.0). Funded by: Research Council of Finland, Finnish Medical Society Duodecim, Helsinki Uusimaa Hospital District, Special state funding.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Introduction

To evaluate predicting clinical factors for regression and progression of cervical intraepithelial neoplasia (CIN) grade 2 (CIN2) in young women during two years of active surveillance. Material and Methods This was a single‐center prospective observational cohort study. Women under 31 years of age giving written informed consent with histologically confirmed CIN2 were followed with colposcopy, cytology, and biopsies every 6 months up to 24 months. At baseline, HPV genotyping was performed on cervical samples. The rates of regression and progression were recorded for every timepoint and at the end of study overall and stratified according to clinical factors and HPV genotypes at baseline. Risk ratio (RR) was used to estimate the relative risks for regression and progression. The study was registered in the ISRCTN registry (ISRCTN91953024).

Results

In total, 205/243 (84.4%) women completed the study. Complete regression (normal histology and/or normal or atypical squamous cells of undetermined significance (ASC‐US) cytology) was detected in 64.4.% ( n = 132) while 16.1% ( n = 33) of the lesions progressed to CIN grade 3 (CIN3) or worse including 31 CIN3 cases, one adenocarcinoma in situ and one cervical cancer case. Factors associated with progression were initial large (>50% of the transformation zone) lesion size, risk ratio (RR) 3.06 (95% confidence interval (CI) 1.40–6.69), and high‐grade referral cytology RR 4.73 (95% CI 1.18–19.03). Compared with baseline HPV negativity or having only low‐risk HPV genotypes present, high‐risk HPV (hrHPV) positivity was associated with lower likelihood of regression RR 0.74 (95% CI 0.60–0.91). Age, cigarette smoking, use of combined oral contraceptives or baseline high‐risk HPV genotype, including HPV16, were not associated with the outcomes.

Conclusions

The majority of CIN2 lesions regress in young women. Women with large lesions and/or high‐grade referral cytology should perhaps more often be treated instead of active surveillance. Initial hrHPV genotype does not appear to predict outcomes while not harboring hrHPV favors regression.

Subjects

MeSH terms (MEDLINE)

Uterine Cervical DysplasiaUterine Cervical NeoplasmsPapillomavirus InfectionsHumansFemaleProspective StudiesAdultDisease ProgressionYoung AdultColposcopyPapillomaviridaeWatchful WaitingGenotypeNeoplasm Grading

Author keywords

HPV genotypeactive surveillancecervical cytologycervical intraepithelial neoplasia grade 2 (CIN2)colposcopylarge loop excision of the transformation zone (LLETZ)

Authors and institutions

  • Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
  • Department of Pathology, University of Helsinki and HUS Diagnostic Center, Helsinki University Hospital, Helsinki, Finland.
  • Department of Metabolism, Digestion and Reproduction, Faculty of Medicine, Institute of Reproductive and Developmental Biology, Imperial College, London, UK.
  • Department of Obstetrics and Gynecology, Hyvinkää Hospital, Helsinki University Hospital and University of Helsinki, Hyvinkää, Finland.
  • Department of Obstetrics and Gynecology, Tampere University Hospital, Tampere, Finland.
  • Department of Obstetrics and Gynecology, Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.

ORCID profiles: Laura Bergqvist, Anni Virtanen, Karolina Louvanto, Karoliina Aro

Funding

  • Research Council of Finland
  • Finnish Medical Society Duodecim
  • Helsinki Uusimaa Hospital District, Special state funding
  • Academy of Finland
  • Suomalainen Lääkäriseura Duodecim

Cite

APA

Bergqvist, L., Virtanen, A., Kalliala, I., Bützow, R., Jakobsson, M., Heinonen, A., Louvanto, K., Dillner, J., Nieminen, P., & Aro, K. (2025). Predictors for regression and progression of actively surveilled cervical intraepithelial neoplasia grade 2: A prospective cohort study. Acta Obstetricia et Gynecologica Scandinavica, 104(4), 763-773. https://doi.org/10.1111/aogs.15032

Vancouver

Bergqvist L, Virtanen A, Kalliala I, Bützow R, Jakobsson M, Heinonen A, et al. Predictors for regression and progression of actively surveilled cervical intraepithelial neoplasia grade 2: A prospective cohort study. Acta Obstetricia et Gynecologica Scandinavica. 2025;104(4):763-773. doi:10.1111/aogs.15032

BibTeX
@article{Bergqvist2025,
  author = {Bergqvist, Laura and Virtanen, Anni and Kalliala, Ilkka and Bützow, Ralf and Jakobsson, Maija and Heinonen, Annu and Louvanto, Karolina and Dillner, Joakim and Nieminen, Pekka and Aro, Karoliina},
  title = {Predictors for regression and progression of actively surveilled cervical intraepithelial neoplasia grade 2: A prospective cohort study},
  journal = {Acta Obstetricia et Gynecologica Scandinavica},
  year = {2025},
  volume = {104},
  number = {4},
  pages = {763--773},
  doi = {10.1111/aogs.15032}
}
Start for free →